Robert C. Bast
Impact in
- Reproductive Medicine top 0.01%
- Ovarian cancer diagnosis and treatment
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
Papers in
-
- Glycosylation and Glycoproteins Research 33
- Epigenetics and DNA Methylation 30
-
- Ovarian cancer diagnosis and treatment 193
- Co-authors
- Gordon B. Mills (53 shared papers)Robert C. Knapp (46 shared papers)Ian Jacobs (30 shared papers)Andrew Berchuck (53 shared papers)Daniel F. Hayes (8 shared papers)Jonathan M. Niloff (15 shared papers)Mark R. Somerfield (5 shared papers)Bryan T. Hennessy (3 shared papers)
- Journals
- Gynecologic Oncology (47 papers)Cancer (37 papers)American Journal of Obstetrics and Gynecology (36 papers)Journal of Clinical Oncology (33 papers)Cancer Research (29 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Robert C. Bast
599 papers receiving 43.3k citations
Robert C. Bast's Hit Papers
Peers
Comparison fields: 5 of 179
- Reproductive Medicine 13.7k
- Cancer Research 9.6k
- Obstetrics and Gynecology 4.1k
- Oncology 13.7k
- Immunology 6.9k
Countries citing papers authored by Robert C. Bast
This map shows the geographic impact of Robert C. Bast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Bast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Bast more than expected).
Fields of papers citing papers by Robert C. Bast
This network shows the impact of papers produced by Robert C. Bast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Bast. The network helps show where Robert C. Bast may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert C. Bast, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 608 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer Hit paper breakdown → | 1983 | 1708 |
| 2 | American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer Hit paper breakdown → | 2007 | 1670 |
| 3 | Reactivity of a monoclonal antibody with human ovarian carcinoma. Hit paper breakdown → | 1981 | 1323 |
| 4 | ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer Hit paper breakdown → | 2006 | 1185 |
| 5 | The biology of ovarian cancer: new opportunities for translation Hit paper breakdown → | 2009 | 1071 |
| 6 | Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer Hit paper breakdown → | 2004 | 741 |
| 7 | The CA 125 tumour-associated antigen: a review of the literature Hit paper breakdown → | 1989 | 729 |
| 8 | Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A Hit paper breakdown → | 2000 | 688 |
| 9 | 2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology* Hit paper breakdown → | 2001 | 660 |
| 10 | A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Hit paper breakdown → | 2008 | 641 |
| 11 | Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Hit paper breakdown → | 1988 | 599 |
| 12 | Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Hit paper breakdown → | 2016 | 576 |
| 13 | Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers Hit paper breakdown → | 1996 | 553 |
| 14 | The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass Hit paper breakdown → | 2007 | 532 |
| 15 | 1994 | 485 | |
| 16 | Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125 Hit paper breakdown → | 1983 | 485 |
| 17 | 1993 | 397 | |
| 18 | Overexpression and mutation of p53 in epithelial ovarian cancer. | 1991 | 393 |
| 19 | 2008 | 376 | |
| 20 | 2004 | 367 |
About Robert C. Bast
Robert C. Bast is a scholar working on Molecular Biology, Reproductive Medicine, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 608 papers that have together received 44.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (193 papers), Monoclonal and Polyclonal Antibodies Research (91 papers), HER2/EGFR in Cancer Research (49 papers), Endometrial and Cervical Cancer Treatments (42 papers), Cancer-related Molecular Pathways (41 papers), Glycosylation and Glycoproteins Research (33 papers), Epigenetics and DNA Methylation (30 papers) and Reproductive System and Pregnancy (28 papers). The work is most often cited by research in Reproductive Medicine (13.7k citations), Cancer Research (9.6k citations), Obstetrics and Gynecology (4.1k citations), Oncology (13.7k citations) and Immunology (6.9k citations). Robert C. Bast has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Gordon B. Mills, Robert C. Knapp, Ian Jacobs, Andrew Berchuck, Daniel F. Hayes, Jonathan M. Niloff, Mark R. Somerfield, Bryan T. Hennessy, Robert Mennel and Robert B. Colvin. Their work appears in journals such as Gynecologic Oncology, Cancer, American Journal of Obstetrics and Gynecology, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.